Molecular diagnostics for melanoma
Subtitle: methods and protocols
By: edited by Magdalena Thurin, Cancer Diagnosis Program, National Cancer Institute, National Institutes of Health, Betheseda, MD, USA, Francesco M. Marincola, Sidra Medical  and Research Center, Qatar Foundation, Doha, Qatar
Contributors: Springer Science+Business Media
Series: Methods in molecular biology -- 1102; Springer protocols; Methods in molecular biology (Clifton, N.J.) -- v. 1102.; Springer protocols (Series)
Publisher: Humana Press
Published: 2014
Place of publication: New York
Language: eng
Number of pages: 712
ISBN-13: 9781627037266; 9781627037273
Copyright date: 2014
Subjects: Melanoma; Laboratory manuals; Molecular diagnosis; Laboratory Manuals; Diagnosis; Biological Markers; Analysis; Molecular Diagnostic Techniques; Methods
Notes: Includes bibliographical references and index.
Table of contents: title: Novel insights/translational implication from the emerging biology of melanoma  -- Antoni Ribas; title: Emerging clinical issues in melanoma in the molecularly targeted era  -- Ryan J. Sullivan and Michael B. Atkins; title: Integrating molecular biomarkers into current clinical management in melanoma  -- Ragini Kudchadkar, Geoffrey Gibney, and Vernon K. Sondak; title: Advances in adjuvant therapy : potential for prognostic and predictive biomarkers  -- Diwakar Davar [and three others]; title: Immunologic monitoring of cancer vaccine trials using the ELISPOT assay  -- Lisa H. Butterfield and Mary Jo Buffo; title: Markers for anti-cytotoxic T-lymphocyte antigen 4 (CTLA- 4) therapy in melanoma  -- Michael A. Postow [and four others]; title: Marker utility for combination therapy  -- Ester Simeone, Antonio M. Grimaldi, and Paolo A. Ascierto; title: Assaying for BRAF V600E in tissue and blood in melanoma  -- David J. Panka, James W. Mier, and Ryan J. Sullivan; title: Selecting patients for KIT inhibition in melanoma  -- Richard D. Carvajal, Omid Hamid, and Cristina R. Antonescu; title: Detecting mechanisms of acquired BRAF inhibitor resistance in melanoma  -- Roger S. Lo and Hubing Shi; title: Current status of diagnostic and prognostic markers in melanoma  -- Danielle Levine and David E. Fisher; title: Chromosomal copy number analysis in melanoma diagnostics  -- Jeffrey P. North, Swapna S. Vemula, and Boris C. Bastian; title: Construction and analysis of multiparameter prognostic models for melanoma outcome  -- Bonnie E. Gould Rothberg and David L. Rimm; title: Immunohistochemical diagnostic and prognostic markers for melanoma  -- Mehdi Nosrati and Mohammed Kashani-Sabet; title: Lymphatic invasion as a prognostic biomarker in primary cutaneous melanoma  -- Xiaowei Xu [and four others]; title: Tumor-infiltrating lymphocytes and their significance in melanoma prognosis  -- Tobias Schatton [and three others]; title: Pathological staging of melanoma  -- David E. Elder; title: Genotyping of human leukocyte antigen (HLA) ancestral haplotypes as prognostic marker in cancer using PCR analysis  -- Lisa Villabona [and three others]; title: B7-H abnormalities in melanoma and clinical relevance  -- Barbara Seliger; title: Melanoma susceptibility genes and risk assessment  -- Alexander Marzuka-Alcalá, Michele Jacobs Gabree, and Hensin Tsao; title: Clinical, pathologic, and imaging features and biological markers of uveal melanoma  -- Alia B. Rashid and Hans E. Grossniklaus; title: Prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile  -- J. William Harbour; title: Molecular karyotyping for detection of prognostic markers in fine needle aspiration biopsy samples of uveal melanoma  -- Arupa Ganguly, Jennifer Richards-Yutz, and Kathryn G. Ewens; title: ERBB4 mutation analysis : emerging molecular target for melanoma treatment  -- Christopher Lau [and three others]; title: Epigenetic markers of prognosis in melanoma  -- Luca Sigalotti [and four others]; title: Isolation of melanoma cell subpopulations using negative selection  -- Ana Slipicevic [and three others]; title: Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients  -- Eiji Kiyohara [and three others]; title: Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma  -- Yangyang Wang [and three others]; title: Targeting damage-associated molecular pattern molecules (DAMPs) and DAMP receptors in melanoma  -- Brian A. Boone and Michael T. Lotze; title: The clinical use of PET/CT in the evaluation of melanoma  -- Khun Visith Keu and Andrei H. Iagaru; title: Immune system functional pathway analysis using single cell network profiling (SCNP) : a novel tool in cancer immunotherapy  -- Alessandra Cesano and David Spellmeyer; title: Quantitative and spatial image analysis of tumor and draining lymph nodes using immunohistochemistry and high-resolution multispectral imaging to prdict metastasis  -- Kim R.M. Blenman and Peter P. Lee; title: COLD-PCR enriches low-level variant DNA sequences and increases the sensitivity of genetic testing  -- Elena Castellanos-Rizaldos [and seven others]; title: Isolation of circulating microRNAs from microvesicles found in human plasma  -- John F. Quackenbush [and seven others]; title: Detection of circulating tumor cells by photoacoustic flowmetry  -- Ryan M. Weight and John A. Viator; title: Statistical design and evaluation of biomarker studies  -- Kevin K. Dobbin; title: Tissue resources for clinical use and marker studies in melanoma -- Jonathan L. Curry [and five others].